LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Jul 30, 2022
Data Byte
Assessing an expanse of ALS targets
Restoring neurotransmission may be the key to slowing fatal disease
Read More
BioCentury
|
Jan 30, 2021
Product Development
ALS looks up as clinical pipeline explodes
Three late-stage readouts this year and multiple mechanisms in the clinic could lift the lid on ALS treatments
Read More
BioCentury
|
Oct 3, 2019
Targets & Mechanisms
ALS platform trial to put neuroinflammation hypothesis to the test
The idea that neuroinflammation drives ALS will get its most rigorous test to date with the Healey ALS platform trial.
Read More
BioCentury
|
May 1, 2019
Translation in Brief
White matter matters in Alzheimer’s
Single-cell transcriptomes reveal myelin role, cell type-specific markers in Alzheimer’s
Read More
BioCentury
|
Sep 28, 2018
Tools & Techniques
Deconstructing tox in immuno-oncology
Reverse translating better preclinical models of cancer immunotherapy tox
Read More
BioCentury
|
Jun 13, 2013
Distillery Therapeutics
Indication: Infectious disease
Read More
BioCentury
|
May 16, 2013
Cover Story
Eritoran insight for influenza treatment
Read More
BioCentury
|
Apr 15, 2013
Company News
Panax Pharmaceutical Ltd., Sangen Pharmaceutical Co. deal
Read More
BioCentury
|
Mar 11, 2013
Clinical News
Cenicriviroc: Additional Phase IIb data
Read More
BioCentury
|
Jan 21, 2010
Distillery Therapeutics
Indication: Infectious disease
Read More
Items per page:
10
1 - 10 of 24